Anti-SLIK5/ SLITRK5/ LRRC11 monoclonal antibody
Anti-SLIK5/ SLITRK5/ LRRC11 antibody for FACS & in-vivo assay
Go to SLITRK5/SLITRK5 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)
Product information
Catalog No. | Product Name | Species Reactivity |
---|---|---|
GM-Tg-hg-MP1687-Ab-1/ GM-Tg-hg-MP1687-Ab-2 | Anti-Human SLITRK5 monoclonal antibody | Human |
GM-Tg-rg-MP1687-Ab-1/ GM-Tg-rg-MP1687-Ab-2 | Anti-Rat SLITRK5 monoclonal antibody | Rat |
GM-Tg-mg-MP1687-Ab-1/ GM-Tg-mg-MP1687-Ab-2 | Anti-Mouse SLITRK5 monoclonal antibody | Mouse |
GM-Tg-cynog-MP1687-Ab-1/ GM-Tg-cynog-MP1687-Ab-2 | Anti-Cynomolgus/ Rhesus macaque SLITRK5 monoclonal antibody | Cynomolgus/ Rhesus macaque |
GM-Tg-felg-MP1687-Ab-1/ GM-Tg-felg-MP1687-Ab-2 | Anti-Feline SLITRK5 monoclonal antibody | Feline |
GM-Tg-cang-MP1687-Ab-1/ GM-Tg-cang-MP1687-Ab-2 | Anti-Canine SLITRK5 monoclonal antibody | Canine |
GM-Tg-bovg-MP1687-Ab-1/ GM-Tg-bovg-MP1687-Ab-2 | Anti-Bovine SLITRK5 monoclonal antibody | Bovine |
GM-Tg-equg-MP1687-Ab-1/ GM-Tg-equg-MP1687-Ab-2 | Anti-Equine SLITRK5 monoclonal antibody | Equine |
Size: 1mg | 10mg | 100mg
Product Description
Catalog No. | GM-Tg-hg-MP1687-Ab-1/ GM-Tg-hg-MP1687-Ab-2; GM-Tg-rg-MP1687-Ab-1/ GM-Tg-rg-MP1687-Ab-2; GM-Tg-mg-MP1687-Ab-1/ GM-Tg-mg-MP1687-Ab-2; GM-Tg-cynog-MP1687-Ab-1/ GM-Tg-cynog-MP1687-Ab-2; GM-Tg-felg-MP1687-Ab-1/ GM-Tg-felg-MP1687-Ab-2; GM-Tg-cang-MP1687-Ab-1/ GM-Tg-cang-MP1687-Ab-2; GM-Tg-bovg-MP1687-Ab-1/ GM-Tg-bovg-MP1687-Ab-2; GM-Tg-equg-MP1687-Ab-1/ GM-Tg-equg-MP1687-Ab-2 |
Products Name | Anti-SLITRK5 monoclonal antibody |
Format | mab |
Target Name | SLITRK5 |
Protein Sub-location | Transmembrane Protein |
Category of antibody | FACS/Biofunctional Antibody |
Derivation (species) | Mouse |
CH1+2+3 Isotype (Receptor identification) | IgG |
Type of Light Chain (VD-LC) | N/A |
Expression platform | Mammalian Expression |
Bioactivity validation | Binding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD). |
Tag | Fc |
Products description | Pre-made anti-SLITRK5 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
Category | Cat No. | Products Name |
Target Antigen | Products Developing | Multi-species SLIK5/ SLITRK5/ LRRC11 VLP (virus-like particle) (Products Developing) |
ORF Viral Vector | pGMLPm004768 | mouse Slitrk5 Lentivirus plasmid |
ORF Viral Vector | vGMLPm004768 | mouse Slitrk5 Lentivirus particle |
Target information
Target ID | GM-MP1687 |
Target Name | SLITRK5 |
Gene ID | 26050,75409,306152,705032,485513,101093488,781586,100050289 |
Gene Symbol and Synonyms | 2610019D03Rik,bA364G4.2,LRRC11,SLITRK5 |
Uniprot Accession | O94991 |
Uniprot Entry Name | SLIK5_HUMAN |
Protein Sub-location | Transmembrane Protein |
Category | |
Disease | N/A |
Gene Ensembl | ENSG00000165300 |
Target Classification | N/A |
The target: SLITRK5, gene name: SLITRK5, also named as LRRC11, bA364G4.2. Members of the SLITRK family, such as SLITRK5, are integral membrane proteins with 2 N-terminal leucine-rich repeat (LRR) domains similar to those of SLIT proteins (see SLIT1; MIM 603742). Most SLITRKs, including SLITRK5, also have C-terminal regions that share homology with neurotrophin receptors (see NTRK1; MIM 191315). SLITRKs are expressed predominantly in neural tissues and have neurite-modulating activity (Aruga et al., 2003 [PubMed 14557068]).[supplied by OMIM, Mar 2008].
About Gmab
GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.